Back to the search results

Immanuel Krankenhaus Berlin - Standort Buch

Immanuel Krankenhaus Berlin - Standort Buch
Immanuel Krankenhaus Berlin - Standort Buch

Lindenberger Weg 19
13125 Berlin

Phone: 030-805-0
Fax: 030-94792-269
Mail: ed.leunammi@nilreb

  • Number of beds: 85
  • Number of specialist departments: 2
  • Number of inpatient cases: 2.071
  • Number of partial inpatient cases: 98
  • Number of outpatient cases: 17.824
  • Hospital owners: Immanuel-Krankenhaus GmbH
  • Type of provider: freigemeinnützig
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of the minimum quantity agreement
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
9 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
8 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
8 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? Yes
  • No care for children and young people
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Name of the working group: Antibiotic-Stewardship
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Prof. Krause: Beirat "Aktuelle Rheumatologie" und "Arthritis&Rheuma" Prof. Schmidt: "Introductory guide to musculoskeletal ultrasound for the rheumatologist"; Lehrbuch Springer Verlag, 3. Auflage 2023

Explanation

Prof. Krause, Prof. Schmidt: Secukinumab bei Riesenzellarteriitis Phase 2, ClinicalTrials.gov Identifier NCT03765788

Explanation

Prof. Krause u. Prof. Schmidt: Mayo Clinic, Univers. Oxford, Univers. Southend, Univers. Leeds (GB), UCLA (Univers. Los Angeles), Univers. Graz u. Wien (Österreich), Univers. Paris, Univers. Barcelona, Univers. Düsseldorf, Univers. Leipzig, Univers. Freiburg, Univers. Mannheim

Explanation

Prof. Krause, Prof. Schmidt: versch. internistisch-rheumatologische Lehrveranstaltungen im Rahmen des Modellstudienganges an der Charité, Ausbildung von Studierenden im Prakt. Jahr, Staatsexamensprüfung Innere Medizin im Studiengang Zahnmedizin

Explanation

Prof. Krause, Prof. Schmidt: mehrere Studien

Explanation

Evaluation einer offenen rheumat. Sprechstunde; J. Koch: Untersuchungen z. Pathogenese v. Interstitiellen Lungenerkrankungen b. rheumatoider Arthritis u. systemischer Sklerose mittels Transkriptomanalyse

Explanation

Prof. Krause und Prof. Schmidt lehren an der Charité

Explanation

Prof. Krause: Studie zur Pathogenese von interstitiellen Lungenerkrankungen mittels Transkriptomanalyse; Prof. Schmidt: Eular Recommendations on Imaging in Large Vessel Vasculitis, OMERACT Ultrasound Subtask Force Gout, OMERACT Ultrasound Subtask Force Large Vessel Vasculitis,

Training in other healing professions
Comment

Ausbildung eigener Auszubildender an der Akademie der Gesundheit in Berlin Buch und Kooperationspartner für die praktische Ausbildung

Comment

Kooperationspartner für die praktische Ausbildung

Werner Zingler

Patientenfürsprecher

Lindenberger Weg 19
13125 Berlin

Phone: 030 -94792-358
Mail: ed.nenitreblaleunammi@relgniz.renrew

Bath Renate

Patientenfürsprecher

Lindenberger Weg 19
13125 Berlin

Phone: 030 -94792-322
Mail: ed.nenitreblaleunammi@htab.etaner

Anne Klatt

Qualitätsmanagement und Sozialdienst

Lindenberger Weg 19
13125 Berlin

Phone: 030 -94792-410
Mail: ed.nenitreblaleunammi@ttalk.enna

Thomas Fricke

Bereichsleitung und Qualitätsmanagement

Lindenberger Weg 19
13125 Berlin

Phone: 0173 -4781871-
Mail: ed.nenitreblaleunammi@ekcirf.samoht

Dr. med. Georg Garanin

Chefarzt

Lindenberger Weg 19
13125 Berlin

Phone: 030 -80505-920
Mail: ed.nenitreblaleunammi@ninarag.groeg

Diplom-Sozialwissenschaftlerin Anne Klatt

Qualitätsmanagementbeauftragte/Mitarbeiterin im Sozialdienst

Lindenberger Weg 19
13125 Berlin

Phone: 030 -94792-410
Mail: ed.nenitreblaleunammi@ttalk.enna

Lindenberger Weg 19
13125 Berlin

Phone: 030-805-0
Fax: 030-94792-269
Mail: ed.leunammi@nilreb

Dipl. - Pflegewirtin Martina Kringe

Pflegedirektorin

Lindenberger Weg 19
13125 Berlin

Phone: 030 -94792-500
Mail: ed.nenitreblaleunammi@egnirk.anitram

Dipl.-Kfm. Roy J. Noack

Geschäftsführer

Lindenberger Weg 19
13125 Berlin

Phone: 030 -94792-401
Mail: ed.nenitreblaleunammi@kcaon.j.yor

Dipl.-Kfm. Roy J. Noack

Geschäftsführer

Lindenberger Weg 19
13125 Berlin

Phone: 030 -80505-257
Mail: ed.nenitreblaleunammi@kcaon.j.yor

Prof Dr. med. Andreas Krause

Ärztlicher Direktor/Chefarzt der Inneren Medizin/Rheumatologie

Lindenberger Weg 19
13125 Berlin

Phone: 030 -94792-300
Mail: ed.nenitreblaleunammi@esuark.saerdna

IK: 261100504

Location number: 772973000

Old location number: 772973000